Why Magnesium Matters More Than Ever During Pregnancy

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Quick answer:

Magnesium requirements rise from 310–320 mg to 350–360 mg daily during pregnancy, yet most prenatal vitamins supply only 50–100 mg, leaving a significant gap. Serum magnesium stays normal even when tissue stores are depleted, which is why RBC magnesium is the accurate marker. Deficiency can drive leg cramps, preeclampsia, and preterm contractions.

Read more →

Understand what your supplement safety results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Why magnesium demands increase during pregnancy

Magnesium is a cofactor in more than 300 enzymatic reactions, including those that regulate DNA synthesis, protein production, and energy metabolism. During pregnancy, these processes accelerate as the fetus builds bone, muscle, and nervous tissue at a rate that places continuous demand on maternal stores.

Maternal blood volume expands by 40 to 50%, diluting circulating magnesium concentrations. Renal magnesium excretion also increases as glomerular filtration rate rises, meaning more magnesium is lost through urine. The recommended dietary allowance increases from 310 to 320 mg per day in non-pregnant women to 350 to 360 mg per day during pregnancy (2019 non-rct observational study). This increment reflects the combined needs of maternal physiology and fetal growth.

When intake doesn't keep pace, the body prioritizes fetal needs by pulling magnesium from maternal bone and soft tissue. This depletion is often silent until symptoms emerge, such as muscle cramps, irritability, or more serious complications like preeclampsia or preterm contractions. Standard prenatal testing rarely includes magnesium, and when it does, it typically measures serum magnesium, which reflects less than 1% of total body stores and remains normal even when tissue levels are depleted.

What the clinical trials show on magnesium and pregnancy complications

The evidence for magnesium's role in preventing serious pregnancy complications is robust, particularly for preeclampsia and preterm birth. Magnesium sulfate, administered intravenously, is the standard of care for women with preeclampsia with severe features. A loading dose of 4 to 6 grams followed by a maintenance infusion of 1 to 2 grams per hour reduces the risk of eclamptic seizures by roughly half (about 50 to 58 percent). This effect is mediated by magnesium's action as a natural calcium antagonist, which stabilizes neuronal membranes and reduces cerebral vasospasm.

For preterm labor, magnesium sulfate has been used as a tocolytic agent to relax uterine smooth muscle, though its efficacy for halting labor is modest and the FDA has advised against prolonged use for this indication due to potential fetal risks with extended exposure. However, short-term administration before anticipated preterm birth below 30 weeks is recommended for fetal neuroprotection. Multiple randomized controlled trials have demonstrated that antenatal magnesium sulfate reduces the risk of cerebral palsy in surviving preterm infants.

Oral magnesium supplementation has been studied for its potential to prevent preeclampsia and preterm labor in lower-risk populations:

  • A Cochrane review found that magnesium supplementation during pregnancy may reduce the risk of fetal growth restriction and preeclampsia, though the quality of evidence is moderate and effect sizes are modest (2019 meta-analysis).
  • One trial using 365 mg of magnesium citrate daily during the first 18 weeks of gestation found a reduction in preeclampsia incidence, but results have not been consistently replicated across all studies.
  • Oral magnesium supplementation at moderate doses has been studied for nocturnal leg cramps during pregnancy, with some trials reporting reduced frequency and intensity.

The mechanism for cramp reduction involves magnesium's role in regulating neuromuscular transmission and muscle relaxation. Deficiency increases neuronal excitability and enhances muscle contraction, making cramps more likely.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

How magnesium works to prevent cramps, preeclampsia, and preterm labor

Neuromuscular regulation and cramp prevention

Magnesium modulates the activity of N-methyl-D-aspartate (NMDA) receptors, which regulate excitatory neurotransmission. When magnesium is deficient, NMDA receptors become overactive, increasing neuronal firing and muscle excitability. This heightened excitability manifests as spontaneous muscle contractions, or cramps. Magnesium also regulates the sodium-potassium pump, which maintains the electrical gradient across muscle cell membranes. Without adequate magnesium, this pump becomes less efficient, further increasing the likelihood of involuntary contractions.

Calcium antagonism and preeclampsia prevention

Preeclampsia is characterized by widespread endothelial dysfunction, vasoconstriction, and elevated blood pressure. Magnesium counteracts these processes by blocking calcium channels in vascular smooth muscle, preventing excessive vasoconstriction. It also stabilizes endothelial cells, reducing oxidative stress and inflammation. In the brain, magnesium prevents cerebral vasospasm and reduces the risk of seizures by dampening neuronal hyperexcitability.

Uterine relaxation and preterm labor prevention

The myometrium (the muscular layer of the uterus) contracts in response to calcium influx. Magnesium inhibits this influx, reducing the frequency and intensity of uterine contractions. This mechanism underlies magnesium sulfate's use as a tocolytic, though its effectiveness is limited and it is no longer recommended for prolonged tocolysis. However, the principle remains relevant: adequate magnesium status supports normal uterine quiescence during pregnancy, while deficiency may predispose to preterm contractions.

Dose, form, and timing: What the evidence supports

Form

Not all magnesium supplements are absorbed equally. Magnesium oxide, commonly found in over-the-counter supplements, has poor bioavailability and often causes diarrhea due to its osmotic effect in the gut. Magnesium glycinate and magnesium citrate are better absorbed and better tolerated. Glycinate is chelated to the amino acid glycine, which itself has calming properties and may enhance the supplement's effect on sleep and muscle relaxation. Citrate is also well absorbed and has a mild laxative effect, which can be beneficial for women experiencing pregnancy-related constipation.

Dose

The recommended daily intake during pregnancy is 350 to 360 mg. Most prenatal vitamins contain 50 to 100 mg of magnesium, leaving a gap that must be filled through diet or additional supplementation. Clinical trials for leg cramps have used 300 to 400 mg of elemental magnesium daily, typically divided into two doses. For preeclampsia prevention, one trial used 365 mg of magnesium citrate daily. The tolerable upper intake level for supplemental magnesium refers to non-food sources and does not include dietary magnesium intake.

Timing

Magnesium is best absorbed when taken with food, as gastric acid enhances solubility. For women experiencing leg cramps, taking magnesium in the evening may be more effective, as cramps most commonly occur at night. Magnesium can also promote relaxation and improve sleep quality, making evening dosing a practical choice. Avoid taking magnesium at the same time as calcium or iron supplements, as these minerals compete for absorption.

Combinations

Magnesium works synergistically with vitamin D. Magnesium is required for the activation of vitamin D in the liver and kidneys, and vitamin D enhances magnesium absorption in the gut. Women who are supplementing with vitamin D should ensure adequate magnesium intake to maximize the benefit. Vitamin B6 also supports magnesium utilization and has been studied for its role in reducing pregnancy-related nausea and leg cramps.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Who responds best to magnesium supplementation, and who should exercise caution

Women who are most likely to benefit from magnesium supplementation during pregnancy include:

  • Those with documented deficiency on RBC magnesium testing.
  • Those experiencing leg cramps or muscle spasms.
  • Those at higher risk for preeclampsia or preterm labor.
  • Those with inadequate dietary intake or gastrointestinal disorders that impair absorption (such as celiac disease or inflammatory bowel disease).
  • Those using medications that deplete magnesium, including proton pump inhibitors and certain diuretics.
  • Those with a history of preeclampsia in a prior pregnancy, chronic hypertension, or kidney disease.
  • Those carrying multiples due to increased fetal demand.

Caution is warranted in women with impaired kidney function, as magnesium is primarily excreted by the kidneys. In the setting of renal insufficiency, magnesium can accumulate to toxic levels, causing muscle weakness, hypotension, and cardiac arrhythmias. Women with myasthenia gravis should also avoid high-dose magnesium, as it can worsen muscle weakness. Magnesium sulfate, when used intravenously for preeclampsia or tocolysis, requires close monitoring of reflexes, respiratory rate, and urine output to detect early signs of toxicity.

Testing your magnesium status: Tracking whether supplementation is working

Serum magnesium is the most commonly ordered test, but it is a poor indicator of total body magnesium status. Because less than 1% of magnesium is in the bloodstream, serum levels can remain normal even when intracellular stores are depleted. RBC magnesium is a more accurate functional marker, as it reflects the magnesium content inside red blood cells, which correlates better with tissue stores.

Symptoms of magnesium deficiency during pregnancy include:

  • Muscle cramps, particularly in the calves.
  • Irritability and mood changes.
  • Fatigue and difficulty sleeping.
  • In more severe cases, preeclampsia, preterm contractions, and abnormal heart rhythms.

Testing RBC magnesium before and during supplementation provides an objective measure of whether intake is adequate and whether supplementation is effective. Other markers that provide context include vitamin D, calcium, and parathyroid hormone, as these nutrients interact closely with magnesium. Inflammatory markers such as high-sensitivity C-reactive protein can also be informative, as chronic inflammation increases magnesium utilization and may contribute to depletion.

Getting a real picture of your magnesium status

Most prenatal panels don't include RBC magnesium, which means most pregnant women supplementing magnesium are doing so without knowing whether they're deficient or whether their dose is effective. Serum magnesium is routinely normal even when tissue stores are low, leaving a significant diagnostic gap. Superpower's 100+ biomarker panel includes RBC magnesium alongside vitamin D, calcium, inflammatory markers, and the hormonal context that determines how well you absorb and use what you're taking. Testing before you supplement transforms guesswork into a personalized protocol, and retesting during pregnancy confirms that your intake is meeting the increased demands of this life stage.

Frequently Asked Questions

References

  1. Zarean E, Tarjan A (2017). Effect of Magnesium Supplement on Pregnancy Outcomes: A Randomized Control Trial. *Advanced biomedical research*, *6*, 109. https://doi.org/10.4103/2277-9175.213879
  2. Bailey RL, Pac SG, Fulgoni VL, Reidy KC, Catalano PM (2019). Estimation of Total Usual Dietary Intakes of Pregnant Women in the United States. *JAMA network open*, *2*(6), e195967. https://doi.org/10.1001/jamanetworkopen.2019.5967
  3. Shepherd E, Salam RA, Manhas D, Synnes A, Middleton P, Makrides M, Crowther CA (2019). Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis. *PLoS medicine*, *16*(12), e1002988. https://doi.org/10.1371/journal.pmed.1002988
  4. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D (2002). Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. *Lancet*, *359*(9321), 1877-1890. https://doi.org/10.1016/S0140-6736(02)08778-0
  5. Makrides M, Crosby DD, Shepherd E, Crowther CA (2014). Magnesium supplementation in pregnancy. *Cochrane Database of Systematic Reviews*, *2014*(4), CD000937. https://doi.org/10.1002/14651858.CD000937.pub2

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey